Healthcare provider profile · identity verified

Franklin C Fleming, MD

Internal Medicine · SAINT PAUL, MN · NPI 1245205962

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	715	185
Amlodipine Besylate	Amlodipine Besylate	589	154
Losartan Potassium	Losartan Potassium	481	123
Levothyroxine Sodium	Levothyroxine Sodium	471	120
Rosuvastatin Calcium	Rosuvastatin Calcium	408	114
Omeprazole	Omeprazole	373	104
Lisinopril	Lisinopril	313	84
Metoprolol Succinate	Metoprolol Succinate	312	97
Eliquis	Apixaban	232	49
Gabapentin	Gabapentin	196	48
Potassium Chloride	Potassium Chloride	194	45
Metformin Hcl Er	Metformin Hcl	186	62
Trazodone Hcl	Trazodone Hcl	186	42
Hydrochlorothiazide	Hydrochlorothiazide	171	46
Tamsulosin Hcl	Tamsulosin Hcl	168	57
Allopurinol	Allopurinol	167	35
Simvastatin	Simvastatin	155	39
Metoprolol Tartrate	Metoprolol Tartrate	143	31
Furosemide	Furosemide	141	34
Sertraline Hcl	Sertraline Hcl	135	33
Spironolactone	Spironolactone	125	26
Donepezil Hcl	Donepezil Hcl	122	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	100	34
Atenolol	Atenolol	99	22
Warfarin Sodium	Warfarin Sodium	98	24
Clopidogrel	Clopidogrel Bisulfate	97	30
Jardiance	Empagliflozin	96	21
Metformin Hcl	Metformin Hcl	93	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	86	25
Xarelto	Rivaroxaban	86	21
Quetiapine Fumarate	Quetiapine Fumarate	84	16
Carvedilol	Carvedilol	83	24
Fluticasone Propionate	Fluticasone Propionate	82	36
Ezetimibe	Ezetimibe	81	27
Mirtazapine	Mirtazapine	81	22
Pantoprazole Sodium	Pantoprazole Sodium	79	26
Alendronate Sodium	Alendronate Sodium	78	19
Venlafaxine Hcl Er	Venlafaxine Hcl	76	13
Albuterol Sulfate Hfa	Albuterol Sulfate	74	37
Gentamicin Sulfate	Gentamicin Sulfate	73	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	73	39
Glipizide Er	Glipizide	72	19
Fluoxetine Hcl	Fluoxetine Hcl	71	15
Escitalopram Oxalate	Escitalopram Oxalate	64	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	64	20
Torsemide	Torsemide	64	19
Duloxetine Hcl	Duloxetine Hcl	63	20
Olanzapine	Olanzapine	57	suppressed
Ozempic	Semaglutide	57	11
Finasteride	Finasteride	54	16
Citalopram Hbr	Citalopram Hydrobromide	53	16
Famotidine	Famotidine	52	16
Bupropion Xl	Bupropion Hcl	50	13
Pravastatin Sodium	Pravastatin Sodium	49	17
Pregabalin	Pregabalin	43	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	41	suppressed
Celecoxib	Celecoxib	39	12
Tamoxifen Citrate	Tamoxifen Citrate	39	suppressed
Farxiga	Dapagliflozin Propanediol	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Myrbetriq	Mirabegron	37	suppressed
Nitroglycerin	Nitroglycerin	37	20
Prednisone	Prednisone	37	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	13
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Chlorthalidone	Chlorthalidone	33	suppressed
Digoxin	Digoxin	33	suppressed
Glimepiride	Glimepiride	33	suppressed
Aripiprazole	Aripiprazole	31	suppressed
Tradjenta	Linagliptin	31	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	29	suppressed
Cephalexin	Cephalexin	27	14
Divalproex Sodium Er	Divalproex Sodium	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	26	16
Diclofenac Sodium	Diclofenac Sodium	24	16
Insulin Lispro Kwikpen U-100	Insulin Lispro	24	suppressed
Vemlidy	Tenofovir Alafenamide	24	suppressed
Glipizide	Glipizide	23	suppressed
Indapamide	Indapamide	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Divalproex Sodium	Divalproex Sodium	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Cefuroxime	Cefuroxime Axetil	19	15
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	11
Admelog Solostar	Insulin Lispro	18	suppressed
Baclofen	Baclofen	18	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	17	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	12
Lansoprazole	Lansoprazole	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Risperidone	Risperidone	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Valsartan	Valsartan	16	suppressed
Irbesartan	Irbesartan	15	suppressed
Klor-Con M10	Potassium Chloride	15	suppressed
Metronidazole	Metronidazole	15	11
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Eplerenone	Eplerenone	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Cholestyramine Light	Cholestyramine	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Colchicine	Colchicine	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error